Inflammatory bowel disease: Costs-of-illness

Journal of Clinical Gastroenterology

Volumn 14, Issue 4, 1992, Pages 309-317

  Hay, Joel W ^a   Hay, Alan R ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Salem Memorial District Hospital   (United States)

Author keywords

Crohn s disease; Epidemiology; Health services utilization; Healthcare costs; Ulcerative colitis

Indexed keywords

AGE; ALGORITHM; ARTICLE; COST; COST BENEFIT ANALYSIS; CROHN DISEASE; ECONOMIC ASPECT; ENTERITIS; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; MEDICAL DECISION MAKING; MEDICAL SERVICE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PRODUCTIVITY; REGRESSION ANALYSIS; ULCERATIVE COLITIS;

ADULT; ALGORITHMS; COLITIS, ULCERATIVE; COSTS AND COST ANALYSIS; CROHN DISEASE; FEMALE; HEALTH CARE COSTS; HUMAN; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MODELS, ECONOMETRIC; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; UNITED STATES;

EID: 0026777406     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/00004836-199206000-00009     Document Type: Article

References (38)

1. Rice DP. Estimating the costs of illness. Health Economics Series No. 6. U.S. Public Health Service, Washington, D.C., 1966.
2. Hay J. Econometric Issues in Modeling the Costs of AIDS. Health Policy 1989;11:125-45.
3. Hay A, Hay J. Inflammatory bowel disease: medical cost algorithms. J Clin Gastroenterol 1992;14:318-27.
4. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J 1982;284:706-9.
5. Benoni C, Nilson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984;19:824-30.
6. Calkins B, et al. Smoking factors in ulcerative colitis and Crohn’s disease in Baltimore. Am J Epidemiol 1984;120:498.
7. Hanauer SB, et al. A case-control study of smoking in inflammatory bowel disease compared to the irritable bowel syndrome. (Abstract). Clin Res 1984;32:223.
8. Logan RFA, et al. Smoking and ulcerative colitis. Br Med J 1984;288:751-3.
9. Sommerville KW, et al. Smoking and Crohn’s disease. Br Med J 1984;289:954-6.
10. Iversen, et al. An epidemiologic model of ulcerative colitis. Scand J Gastroenterol 1968;3:593-601.
11. Myren I, Gjone E, Herzberg JN, et al. Epidemiology of ulcerative colitis and regional enteritis (Crohn’s disease) in Norway. Scand J Gastroenterol 1971;6:511-4.
12. Devlin GB, Datta D, Dellipiani AW. The incidence and prevalence of inflammatory bowel disease in North Tees health district. World J Surg 1980;4:183-93.
13. Calkins B, Mendeloff A. Epidemiology of inflammatory bowel disease. Epidemiol Rev 1986;8:60-91.
14. Stowe S, Redmond S, Stormont J, et al. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Gastroenterology 1990;98:104-16.
15. Kyle J, Stark G. Fall in the incidence of Crohn’s disease. Gut 1980;21:340-3.
16. Sandler RS, Golden, et al. Epidemiology of Crohn’s disease. J Clin Gastroenterol 1986;8:160-5.
17. Sonnenberg A. Geographic variation in the incidence of and mortality from inflammatory bowel disease. Dis Colon Rectum 1986;12:854-61.
18. Hiatt R, Kaufman L. Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med 1988;149:541-6.
19. Both H, et al. Clinical appearance at diagnosis of ulcerative colitis and Crohn’s disease in a regional patient group. Scand J Gastroenterol 1983;18:987-91.
20. Hay J. The impact of public health care financing policies on private sector hospital costs. J Health Polit Policy Law 1983;7:945-52.
21. Yett D, Der W, Ernst R, Hay J. Physician pricing and health insurance reimbursement. Health Care Financ Rev 1983;5:69-80.
22. Gollop J, et al. Epidemiologie aspects of Crohn’s disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988;29:49-5.
23. Binder V, et al. Incidence and prevalence of ulcerative colitis and Crohn’s disease in the county of Copenhagen, 1962 to 1978. Gastroenterology 1982;83:563-8.
24. Hendriksen C, Kreiner S, Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 1985;26:158-63.
25. Wyke RJ, et al. Employment problems and prospects for patients with inflammatory bowel disease. Gut 1988;29:1229-35.
26. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn’s disease. Gastroenterology 1985;88:1818-25.
27. Levit KR, Freeland MS, Waldo DR. National health care spending trends: 1988. Health Affairs 1990;9:171-184.
28. Ricardo-Campbell RC. Business and American health care costs. JJ World Congress of Health Economics, Zurich, Switzerland: September, 1990.
29. White H. Asymptotic theory for econometricians. Orlando, FL: Academic Press, 1984.
30. Hay J. Are cholesterol interventions cost-effective? Abstract. Tenth International Symposium on Drugs Affecting Lipid Metabolism, Houston, TX: November, 1989.
31. American Heart Association. 1989 heart facts. Dallas TX, 1988.
32. Scheffler RM, Andrews NC, Phillips KA, (eds). Cancer care and cost: DRGs and beyond. Ann Arbor: MI: Health Administration Press Perspectives, 1989.
33. Broder S. The human costs of cancer and the response of the National Cancer Program. Cancer 1991;67:1716-7.
34. Hay J, Ernst R. The economic costs of Alzheimer’s disease. Am J Public Health 1987;77:17.
35. Felts W, Yelin E. The economic impact of the rheumatic diseases in the United States. J Rheumatol 1989;16:867-84.
36. Hay J, Osmond D, Wolak F. Projecting the Costs of AIDS and ARC in the United States, Final Report, Grant No. HS 06092-01. Springfield, Va: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services. National Technical Information Service, 1991.
37. Muse D, Oster G, Killen A, Lacey M, Colditz G. The economic costs of non-insulin-dependent diabetes mellitus. JAMA 1989;262:2708-13.
38. Hay J, Daum R. Cost-benefit analysis of Haemophilus influenzae type B prevention: conjugate vaccination at eighteen months of age. Pediatr Infect Dis J 1990;9:246-52.